Literature DB >> 23935336

Body composition in multiple sclerosis.

Y Dionyssiotis1.   

Abstract

Multiple sclerosis affects central nervous system leading to disability. Among other complications the deterioration of body composition is usually neglected and increases the risk for diseases such as coronary heart disease, non-insulin dependent diabetes mellitus, lipid abnormalities and bone loss leading to fractures in this population. Body mass index values, the effect of spasticity, the increased number of drugs used and the relationship between skeletal muscle and bone which interacts with impaired motor function leading to body composition alterations in multiple sclerosis are reviewed.

Entities:  

Keywords:  Multiple sclerosis; body composition; bone; fat; muscle; rehabilitation

Year:  2013        PMID: 23935336      PMCID: PMC3738283     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  58 in total

1.  Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury.

Authors:  M J Castro; D F Apple; E A Hillegass; G A Dudley
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1999-09

2.  The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis.

Authors:  L Paul; D Rafferty; S Young; L Miller; P Mattison; A McFadyen
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

Review 3.  Applicability of body composition techniques and constants for children and youths.

Authors:  T G Lohman
Journal:  Exerc Sport Sci Rev       Date:  1986       Impact factor: 6.230

4.  Overweight, underweight, and mortality. A prospective study of 48,287 men and women.

Authors:  J C Seidell; W M Verschuren; E M van Leer; D Kromhout
Journal:  Arch Intern Med       Date:  1996-05-13

Review 5.  Multiple sclerosis-associated fatigue.

Authors:  Lauren B Krupp; Dana J Serafin; Christopher Christodoulou
Journal:  Expert Rev Neurother       Date:  2010-09       Impact factor: 4.618

Review 6.  Glucocorticoid-induced osteoporosis: an update.

Authors:  Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Journal:  Trends Endocrinol Metab       Date:  2006 May-Jun       Impact factor: 12.015

7.  Prevention of corticosteroid-induced osteoporosis by alfacalcidol.

Authors:  P Lakatos; Z Nagy; L Kiss; C Horvath; I Takacs; J Foldes; G Speer; A Bossanyi
Journal:  Z Rheumatol       Date:  2000       Impact factor: 1.372

8.  Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis.

Authors:  Sevil Kurban; Zehra Akpinar; Idris Mehmetoglu
Journal:  Mult Scler       Date:  2008-01-21       Impact factor: 6.312

9.  Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment.

Authors:  Anat Achiron; Shmuel Edelstein; Y Ziev-Ner; Uri Givon; Zeev Rotstein; Yoram Barak
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

10.  DEXA: a practical and accurate tool to demonstrate total and regional bone loss, lean tissue loss and fat mass gain in paraplegia.

Authors:  L M Jones; A Goulding; D F Gerrard
Journal:  Spinal Cord       Date:  1998-09       Impact factor: 2.772

View more
  1 in total

1.  Nutritional Alterations Associated with Neurological and Neurosurgical Diseases.

Authors:  Yannis Dionyssiotis; Aris Papachristos; Konstantina Petropoulou; Jannis Papathanasiou; Panayiotis Papagelopoulos
Journal:  Open Neurol J       Date:  2016-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.